Figures & data
Figure 1 SEM images of FSCP/COS NFMs with different FSCP/COS mass ratios of 1:3 (A), 1:2 (B), 1:1 (C), 2:1 (D), and 3:1 (E); TEM image of FSCP/COS NFM with FSCP/COS at a mass ratio of 2:1 (F).
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.
![Figure 1 SEM images of FSCP/COS NFMs with different FSCP/COS mass ratios of 1:3 (A), 1:2 (B), 1:1 (C), 2:1 (D), and 3:1 (E); TEM image of FSCP/COS NFM with FSCP/COS at a mass ratio of 2:1 (F).Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.](/cms/asset/b3e8f18a-a605-4990-84bd-4e358ce34436/dijn_a_17547_f0001_b.jpg)
Figure 2 FTIR spectra of COS, FSCP, PVA, and FSCP/COS NFMs.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membrane; PVA, polyvinyl alcohol.
![Figure 2 FTIR spectra of COS, FSCP, PVA, and FSCP/COS NFMs.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membrane; PVA, polyvinyl alcohol.](/cms/asset/fb3b2ed2-a424-459e-ae42-d424e36dd05d/dijn_a_17547_f0002_b.jpg)
Figure 3 Antibacterial activities of different concentration of FSCP/COS NFMs against S. aureus (▴) and E. coli (▪) (A); Antibacterial activities of different NFMs at 0.8 g per sample against S. aureus (B), and E. coli (C).
Note: *P < 0.05 compared with FSCP NFMs.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membranes.
![Figure 3 Antibacterial activities of different concentration of FSCP/COS NFMs against S. aureus (▴) and E. coli (▪) (A); Antibacterial activities of different NFMs at 0.8 g per sample against S. aureus (B), and E. coli (C).Note: *P < 0.05 compared with FSCP NFMs.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membranes.](/cms/asset/8dc54443-0dd7-416a-83c2-58c09bacc3b4/dijn_a_17547_f0003_b.jpg)
Figure 4 SEM images of bacteria attached on the surfaces of FSCP/COS NFMs after 2 hours of incubation.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.
![Figure 4 SEM images of bacteria attached on the surfaces of FSCP/COS NFMs after 2 hours of incubation.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.](/cms/asset/d5524429-4f04-4356-acb3-67f633bea363/dijn_a_17547_f0004_b.jpg)
Figure 5 Photomicrographs of E. coli (A), and S. aureus (B) treated with FSCP/COS NFMs. 1, 2, 3, 4, and 5 refer to the samples at 0, 15, 30, 45, and 60 minutes, respectively.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.
![Figure 5 Photomicrographs of E. coli (A), and S. aureus (B) treated with FSCP/COS NFMs. 1, 2, 3, 4, and 5 refer to the samples at 0, 15, 30, 45, and 60 minutes, respectively.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes.](/cms/asset/6ac31ea7-22c3-4df5-9422-10a530db566c/dijn_a_17547_f0005_b.jpg)
Figure 6 Release of cell materials absorbing at 260 nm (A) and 280 (B) from E. coli or S. aureus suspensions treated with FSCP/COS NFMs, and PVA NFM treatment as a control.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes; PVA, polyvinyl alcohol.
![Figure 6 Release of cell materials absorbing at 260 nm (A) and 280 (B) from E. coli or S. aureus suspensions treated with FSCP/COS NFMs, and PVA NFM treatment as a control.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFMs, nanofibrous membranes; PVA, polyvinyl alcohol.](/cms/asset/10f22d3e-3929-4881-bb98-e38cf372838a/dijn_a_17547_f0006_b.jpg)
Figure 7 Photomicrographs of human skin fibroblasts after growing for 1 day and 7 days, respectively, with treatments of PVA (A, B), COS (C, D), FSCP (E, F), and FSCP/COS (G, H).
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membranes; PVA, polyvinyl alcohol.
![Figure 7 Photomicrographs of human skin fibroblasts after growing for 1 day and 7 days, respectively, with treatments of PVA (A, B), COS (C, D), FSCP (E, F), and FSCP/COS (G, H).Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; NFM, nanofibrous membranes; PVA, polyvinyl alcohol.](/cms/asset/06234920-11f3-4978-b44d-28b237510b7c/dijn_a_17547_f0007_b.jpg)
Figure 8 Fibroblast cell viability using the MTT assays. Fresh medium was used as a negative control and PVA as a positive control. The absorbance was normalized against the negative control at each time interval, which is taken as 100%.
Note: *P < 0.05 compared with the negative control.
Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NFMs, nanofibrous membranes; PVA, polyvinyl alcohol.
![Figure 8 Fibroblast cell viability using the MTT assays. Fresh medium was used as a negative control and PVA as a positive control. The absorbance was normalized against the negative control at each time interval, which is taken as 100%.Note: *P < 0.05 compared with the negative control.Abbreviations: COS, chito-oligosaccharides; FSCP, fish scale collagen peptides; MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NFMs, nanofibrous membranes; PVA, polyvinyl alcohol.](/cms/asset/ae1695e5-9ca2-4332-ba78-6db3b45501f1/dijn_a_17547_f0008_b.jpg)